NifedipineThird Party Manufacturing in India

Nifedipine works by inhibiting the influx of extracellular calcium ions into myocardial and vascular smooth muscle cells.

It specifically blocks L-type calcium channels, leading to the relaxation of vascular smooth muscle and a subsequent decrease in peripheral vascular resistance. This vasodilatory effect helps the body lower blood pressure and reduce the workload on the heart.

Unlike some other antihypertensives, Nifedipine has a pronounced effect on arterial vessels with minimal direct effect on the heart rate, making it highly effective for managing hypertension and chronic stable angina.

Therapeutic Uses

Nifedipine is prescribed for the treatment of:

• Hypertension: For the management of high blood pressure to reduce the risk of cardiovascular events like stroke and myocardial infarction.
• Chronic stable angina: To reduce the frequency and severity of angina attacks by improving myocardial oxygen supply.
• Vasospastic angina (Prinzmetal's angina): To prevent spasms of the coronary arteries.

Why Manufacturers Choose Nifedipine

Nifedipine is a well-established and widely prescribed calcium channel blocker with a large and stable market demand globally. Its availability in various extended-release formulations provides flexibility in patient management and lifecycle extension for brands.

This makes Nifedipine one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies focusing on cardiovascular portfolios.